Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Turcot syndrome 1Rhabdoid Tumor 1Pathologic Complete Response 1Neuroectodermal Tumors, Primitive 1Nasopharyngeal Carcinoma 1Medulloblastoma 1Lung Neoplasms 1Esophagitis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1Brain Neoplasms 1Anus Neoplasms 1

Interventions

Cyclophosphamide 6Vincristine 3Temozolomide 3Radiotherapy 3Cisplatin 3Automobiles 3fludarabine 2Etoposide 2Eflornithine 2Carboplatin 2omburtamab I-131 1ibrutinib 1gallium Ga 68 dotatate 1etoposide phosphate 1belzutifan 1Zoledronic Acid 1Thiotepa 1Tamoxifen 1Standard of Care 1Radiotherapy, Image-Guided 1Pemetrexed 1ONC206 1Nivolumab 1Mesna 1Maintenance Chemotherapy 1Lomustine 1Isotretinoin 1Induction Chemotherapy 1Hydrocortisone 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors, Primitive × Induction Chemotherapy × 1 year × Clear all
NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Universitätsklinikum Hamburg-Eppendorf

Phase 2/3 Active not recruiting
360 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡